8-129752783-C-T
Variant names:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_031415.3(GSDMC):c.759G>A(p.Ala253Ala) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00403 in 1,614,122 control chromosomes in the GnomAD database, including 262 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.022 ( 139 hom., cov: 33)
Exomes 𝑓: 0.0022 ( 123 hom. )
Consequence
GSDMC
NM_031415.3 synonymous
NM_031415.3 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.305
Genes affected
GSDMC (HGNC:7151): (gasdermin C) Predicted to enable phosphatidylinositol-4,5-bisphosphate binding activity; phosphatidylinositol-4-phosphate binding activity; and phosphatidylserine binding activity. Predicted to be involved in defense response to bacterium and pyroptosis. Predicted to act upstream of or within intestinal epithelial cell development. Located in cytoplasm. [provided by Alliance of Genome Resources, Apr 2022]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.81).
BP6
Variant 8-129752783-C-T is Benign according to our data. Variant chr8-129752783-C-T is described in ClinVar as [Benign]. Clinvar id is 713508.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.305 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0732 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
GSDMC | ENST00000276708.9 | c.759G>A | p.Ala253Ala | synonymous_variant | Exon 7 of 14 | 1 | NM_031415.3 | ENSP00000276708.4 | ||
GSDMC | ENST00000522273.5 | n.104G>A | non_coding_transcript_exon_variant | Exon 1 of 8 | 1 | |||||
GSDMC | ENST00000619643.1 | c.759G>A | p.Ala253Ala | synonymous_variant | Exon 6 of 13 | 2 | ||||
GSDMC | ENST00000521365.1 | n.-26G>A | upstream_gene_variant | 3 |
Frequencies
GnomAD3 genomes AF: 0.0217 AC: 3307AN: 152144Hom.: 139 Cov.: 33
GnomAD3 genomes
AF:
AC:
3307
AN:
152144
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00567 AC: 1412AN: 248938Hom.: 50 AF XY: 0.00409 AC XY: 551AN XY: 134748
GnomAD3 exomes
AF:
AC:
1412
AN:
248938
Hom.:
AF XY:
AC XY:
551
AN XY:
134748
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00219 AC: 3197AN: 1461860Hom.: 123 Cov.: 31 AF XY: 0.00185 AC XY: 1343AN XY: 727226
GnomAD4 exome
AF:
AC:
3197
AN:
1461860
Hom.:
Cov.:
31
AF XY:
AC XY:
1343
AN XY:
727226
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0217 AC: 3311AN: 152262Hom.: 139 Cov.: 33 AF XY: 0.0210 AC XY: 1566AN XY: 74446
GnomAD4 genome
AF:
AC:
3311
AN:
152262
Hom.:
Cov.:
33
AF XY:
AC XY:
1566
AN XY:
74446
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
6
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
-
Breakthrough Genomics, Breakthrough Genomics
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: not provided
- -
Aug 20, 2018
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing
- -
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at